Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Douglas Norman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Physiology

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Arnol Miha; de Mattos Angelo M; Chung Jae S; Prather Jonathan C; Mittalhenkle Anuja; Norman Douglas J
Late steroid withdrawal and cardiovascular events in kidney transplant recipients.
Arnol Miha; Prather Jonathan C; Mittalhenkle Anuja; Barry John M; Norman Douglas J
Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center.
Endres R O; Wetzsteon P J; Stein J; Norman D J
A novel DRB1*04 allele.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Douglas Norman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Arnol Miha; de Mattos Angelo M; Chung Jae S; Prather Jonathan C; Mittalhenkle Anuja; Norman Douglas J
Late steroid withdrawal and cardiovascular events in kidney transplant recipients.
Transplantation 2008;86(12):1844-8.
2008: Arnol Miha; Prather Jonathan C; Mittalhenkle Anuja; Barry John M; Norman Douglas J
Long-term kidney regraft survival from deceased donors: risk factors and outcomes in a single center.
Transplantation 2008;86(8):1084-9.
2007: Endres R O; Wetzsteon P J; Stein J; Norman D J
A novel DRB1*04 allele.
Tissue antigens 2007;70(1):76-8.
2007: Alloway Rita; Steinberg Steven; Khalil Kassem; Gourishankar Sita; Miller Joshua; Norman Douglas; Hariharan Sundaram; Pirsch John; Matas Arthur; Zaltzman Jeffrey; Wisemandle Kathleen; Fitzsimmons William; First M Roy
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Transplantation 2007;83(12):1648-51.
2007: Ozawa M; Terasaki P I; Lee J H; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
Tissue antigens 2007;69 Suppl 1():174-9.
2007: Ozawa M; Terasaki P I; Castro R; Alberu J; Morales-Buenrostro L; Alvarez I; Toledo R; Alvez H; Monteiro M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Langan L; Conca R; Grosse-Wilde H; Heinemann F; Kamoun M; Kobayashi T; Kupatawintu P; LeFor W; Mehra N; Panigrahi A; Norman D; Piazza A; Poli F; Roy R; Schonemann C; Lachmann N; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.
Clinical transplants 2007;():255-60.
2006: de Mattos A M; Prather J; Olyaei A J; Shibagaki Y; Keith D S; Mori M; Norman D J; Becker T
Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors.
Kidney international 2006;70(4):757-64.
2006: Norman Douglas J
Kidney paired donation: a single-center study of feasibility and outcomes.
Nature clinical practice. Nephrology 2006;2(6):302-3.
2006: Mittalhenkle Anuja; Norman Douglas J
Tularemia in a renal transplant recipient.
Clinical transplants 2006;():574-5.
2005: Norman Douglas J
The kidney transplant wait-list: allocation of patients to a limited supply of organs.
Seminars in dialysis 2005;18(6):456-9.
2005: Barry John M; Conlin Michael; Golconda Muralikrishna; Norman Douglas
Strategies to increase living donor kidney transplants.
Urology 2005;66(5 Suppl):43-6.
2005: Taylor Gregory S; Prather Jonathan C; Norman Douglas J; de Mattos Angelo M; Mogilishetty Gautham; Conlin Michael J; Barry John M
Living unrelated donor renal transplantation: a single center experience.
The Journal of urology 2005;174(1):223-5.
2005: Keith Douglas S; DeMattos Angelo; Golconda Muralikrishna; Prather Jonathan; Cantarovich Marcelo; Paraskevas Steven; Tchervenkov Jean; Norman Douglas J
Factors associated with improvement in deceased donor renal allograft function in the 1990s.
Journal of the American Society of Nephrology : JASN 2005;16(5):1512-21.
2005: Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First M R
Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Transplantation proceedings 2005;37(2):867-70.
2005: de Mattos Angelo M; Olyaei Ali J; Prather Jonathan C; Golconda Muralikrishna S; Barry John M; Norman Douglas J
Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
Kidney international 2005;67(2):714-20.
2004: Keith Douglas S; Demattos Angelo; Golconda Muralikrishna; Prather Jonathan; Norman Douglas
Effect of donor recipient age match on survival after first deceased donor renal transplantation.
Journal of the American Society of Nephrology : JASN 2004;15(4):1086-91.
2004: Wynn James J; Distant Dale A; Pirsch John D; Norman Douglas; Gaber A Osama; Ashby Valarie B; Leichtman Alan B
Kidney and pancreas transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4 Suppl 9():72-80.
2003: Pescovitz Mark D; Book Benita K; Henson Sharon; Leapman Stephen B; Milgrom Martin L; Kimball Jess; Norman Douglas; Filo Ronald S
The addition of sirolimus to cyclosporine and steroids inhibits the anti-equine antibody response in renal transplant recipients treated with antithymocyte globulin.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(4):497-500.
2003: Golconda Muralikrishna S; de Mattos Angelo M; Prather Jonathan; Olyaei Ali J; Fletcher Lori; Head Mary Ann; Wetzsteon Paula; Barry John M; Norman Douglas J
Renal transplantation at Oregon Health and Science University: recent results and protocols.
Clinical transplants 2003;():149-54.
2002: Lewis Michael S; Wilson Richard A; Walker Kirk W; Wilson Daniel J; Norman Douglas J; Barry John M; Bennett William M
Validation of an algorithm for predicting cardiac events in renal transplant candidates.
The American journal of cardiology 2002;89(7):847-50.
2001: Norman D J; Prather J C; Alkhunaizi A M; deMattos A M; Golconda M; Barry J M
Use of A(2) kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade.
Transplantation proceedings 2001;33(7-8):3327-30.
2000: Norman D J; Vincenti F; de Mattos A M; Barry J M; Levitt D J; Wedel N I; Maia M; Light S E
Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors.
Transplantation 2000;70(12):1707-12.
2000: Legendre C M; Norman D J; Keating M R; Maclaine G D; Grant D M
Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluation.
Transplantation 2000;70(10):1463-8.
2000: Gallay B J; de Mattos A M; Norman D J
Reversible acute renal allograft dysfunction due to gabapentin.
Transplantation 2000;70(1):208-9.
2000: Pescovitz M D; Conti D; Dunn J; Gonwa T; Halloran P; Sollinger H; Tomlanovich S; Weinstein S; Inokuchi S; Kiberd B; Kittur D; Merion R M; Norman D; Shoker A; Wilburn R; Nicholls A J; Arterburn S; Dumont E
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.
Clinical transplantation 2000;14(3):179-88.
2000: Thorp M; DeMattos A; Bennett W; Barry J; Norman D
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol.
Transplantation 2000;69(6):1218-20.
1999: Lewis M S; Wilson R A; Walker K; Stegeman-Olsen J; Norman D J; Barry J M; Bennett W M
Factors in cardiac risk stratification of candidates for renal transplant.
Journal of cardiovascular risk 1999;6(4):251-5.
1999: Alkhunaizi A M; de Mattos A M; Barry J M; Bennett W M; Norman D J
Renal transplantation across the ABO barrier using A2 kidneys.
Transplantation 1999;67(10):1319-24.
1999: Lowance D; Neumayer H H; Legendre C M; Squifflet J P; Kovarik J; Brennan P J; Norman D; Mendez R; Keating M R; Coggon G L; Crisp A; Lee I C
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
The New England journal of medicine 1999;340(19):1462-70.
1999: de Mattos A M; Bennett W M; Barry J M; Norman D J
HLA-identical sibling renal transplantation--a 21-yr single-center experience.
Clinical transplantation 1999;13(2):158-67.
1998: Burlingham W J; Grailer A P; Heisey D M; Claas F H; Norman D; Mohanakumar T; Brennan D C; de Fijter H; van Gelder T; Pirsch J D; Sollinger H W; Bean M A
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors.
The New England journal of medicine 1998;339(23):1657-64.
1998: Olyaei A J; deMattos A M; Norman D J; Bennett W M
Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
Pharmacotherapy 1998;18(6):1356-9.
1998: Alkhunaizi A M; Olyaei A J; Barry J M; deMattos A M; Conlin M J; Lemmers M J; Bennett W M; Norman D J
Efficacy and safety of low molecular weight heparin in renal transplantation.
Transplantation 1998;66(4):533-4.
1998: Gaber A O; First M R; Tesi R J; Gaston R S; Mendez R; Mulloy L L; Light J A; Gaber L W; Squiers E; Taylor R J; Neylan J F; Steiner R W; Knechtle S; Norman D J; Shihab F; Basadonna G; Brennan D C; Hodge E E; Kahan B D; Kahan L; Steinberg S; Woodle E S; Chan L; Ham J M; Schroeder T J
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Transplantation 1998;66(1):29-37.
1998: Lampros T D; Cobanoglu A; Parker F; Ratkovec R; Norman D J; Hershberger R
Squamous and basal cell carcinoma in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(6):586-91.
1997: de Mattos A M; Meyer M M; Norman D J; Bennett W M; Sprague J; Bakke A C
Interleukin-12 p40 m-RNA expression in human kidney allograft biopsies.
Transplant immunology 1997;5(3):199-203.
1997: Norman D J
Allocation of livers for liver transplantation: ethics and politics.
Clinics in liver disease 1997;1(2):281-6, viii.
1997: Payami H; Schellenberg G D; Zareparsi S; Kaye J; Sexton G J; Head M A; Matsuyama S S; Jarvik L F; Miller B; McManus D Q; Bird T D; Katzman R; Heston L; Norman D; Small G W
Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.
Neurology 1997;49(2):512-8.
1997: Cobanoglu A; Lampros T; Hershberger R; Norman D
Ten-year results of the Oregon program with 295 consecutive heart transplants in the Pacific Northwest.
American journal of surgery 1997;173(5):426-30.
1997: Burdick J; Norman D J; Hunsicker L; Costanzo-Nordin M; Edwards E; Bollinger R R
Identification of poorly performing transplant centers using the UNOS center-specific data.
Transplantation proceedings 1997;29(1-2):1495.
1997: Heston T F; Norman D J; Barry J M; Bennett W M; Wilson R A
Cardiac risk stratification in renal transplantation using a form of artificial intelligence.
The American journal of cardiology 1997;79(4):415-7.
1996: Ellison M D; Breen T J; Davies D B; Edwards E B; Mahoney R J; Daily O P; Norman D J
When perfectly HLA-matched kidneys are refused for transplant: implications for a national cooperative sharing system.
Journal of the American College of Surgeons 1996;183(5):434-40.
1996: Bennett W M; DeMattos A; Norman D J; Meyer M M; Olyaei A
Which cyclosporin formulation?
Lancet 1996;348(9021):205.
1996: Mahoney R J; Norman D J; Colombe B W; Garovoy M R; Leeber D A
Identification of high- and low-risk second kidney grafts.
Transplantation 1996;61(9):1349-55.
1996: Abramowicz D; Norman D J; Vereerstraeten P; Goldman M; De Pauw L; Vanherweghem J L; Kinnaert P; Kahana L; Stuart F P; Thistlethwaite J R; Shield C F; Monaco A; Wu S C; Haverty T P
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival.
Kidney international 1996;49(3):768-72.
1996: Barry J M; Lemmers M J; Conlin M J; Norman D J; Bennett W M; Meyer M M; DeMattos A; Wetzsteon P; Johnson-Tomanka M; Seely M
Thirty-seven years of renal transplantation in Oregon.
Clinical transplants 1996;():223-30.
1996: Sharma S; Reddy V; Ott G; Sheppard B; Ratkovec R; Hershberger R; Norman D; Hosenpud J; Cobanoglu A
Gastrointestinal complications after orthotopic cardiac transplantation.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1996;10(8):616-20.
1996: Barry J M; Lemmers M J; Meyer M M; DeMattos A; Bennett W M; Norman D J
Cadaver kidney transplantation in patients more than 65 years old.
World journal of urology 1996;14(4):243-8.
1995: Norman D J
Mechanisms of action and overview of OKT3.
Therapeutic drug monitoring 1995;17(6):615-20.
1995: Kimball J A; Pescovitz M D; Book B K; Norman D J
Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Transplantation 1995;60(12):1379-83.
1995: Kimball J A; Norman D J; Shield C F; Schroeder T J; Lisi P; Garovoy M; O'Connell J B; Stuart F; McDiarmid S V; Wall W
The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
Transplant immunology 1995;3(3):212-21.
1995: Abramowicz D; Norman D J; Goldman M; De Pauw L; Kinnaert P; Kahana L; Thistlethwaite J R; Shield C F; Monaco A P; Vanherweghem J L
OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Transplantation proceedings 1995;27(1):852-3.
1995: Norman D J; Ellison M D; Breen T J; Davies D B; Daily O P
Cadaveric kidney allocation in the United States: a critical analysis of the point system.
Transplantation proceedings 1995;27(1):800.
1995: Henell K R; Norman D J
In vivo pharmacodynamics of Atgam induction immunosuppression in renal transplantation.
Transplantation proceedings 1995;27(1):1052-3.
1994: Norman D J
The distribution of organs for liver transplantation.
JAMA : the journal of the American Medical Association 1994;272(11):848.
1994: Pereira B J; Wright T L; Schmid C H; Bryan C F; Cheung R C; Cooper E S; Hsu H; Heyn-Lamb R; Light J A; Norman D J
Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study.
Kidney international 1994;46(3):886-92.
1994: Ellison M D; Norman D J; Breen T J; Edwards E B; Davies D B; Daily O P
No effect of H-Y minor histocompatibility antigen in zero-mismatched living-donor renal transplants.
Transplantation 1994;58(4):518-20.
1994: Norman D J; Kimball J A; Bennett W M; Shihab F; Batiuk T D; Meyer M M; Barry J M
A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7(5):356-61.
1994: Le A; Wilson R; Douek K; Pulliam L; Tolzman D; Norman D; Barry J; Bennett W
Prospective risk stratification in renal transplant candidates for cardiac death.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1994;24(1):65-71.
1994: Norman D J
Racial inequities in kidney transplantation: the UNOS perspective. United Network for Organ Sharing.
JAMA : the journal of the American Medical Association 1994;271(18):1402-3.
1994: De Mattos A M; Head M A; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman D J
HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
Transplantation 1994;57(4):626-30.
1994: Ott G Y; Norman D J; Hosenpud J D; Hershberger R E; Ratkovec R M; Cobanoglu A
Heart transplantation in patients with previous cardiac operations. Excellent clinical results.
The Journal of thoracic and cardiovascular surgery 1994;107(1):203-9.
1994: Ott G Y; Herschberger R E; Ratkovec R R; Norman D; Hosenpud J D; Cobanoglu A
Cardiac allografts from high-risk donors: excellent clinical results.
The Annals of thoracic surgery 1994;57(1):76-81; discussion 81-2.
1994: Everett J P; Hershberger R E; Ratkovec R M; Norman D J; Cobanoglu A; Ott G Y; Hosenpud J D
The specificity of normal qualitative angiography in excluding cardiac allograft vasculopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1994;13(1 Pt 1):142-8; discussion 148-9.
1994: Wilson R A; Norman D J; Barry J M; Bennett W M
Noninvasive cardiac testing in the end-stage renal disease patient.
Blood purification 1994;12(1):78-83.
1993: Robinson S T; Barry J M; Norman D J
The hemodynamic effects of intraoperative injection of muromonab CD3.
Transplantation 1993;56(2):356-8.
1993: Ott G Y; Norman D; Ratkovec R R; Hershberger R E; Hosenpud J D; Cobanoglu A
ABO-incompatible heart transplantation: a special case for the A2 donor.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993;12(3):504-7.
1993: Norman D J; Chatenoud L; Cohen D; Goldman M; Shield C F
Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.
Transplantation proceedings 1993;25(2 Suppl 1):89-92.
1993: Henell K R; Norman D J
Monitoring OKT3 treatment: pharmacodynamic and pharmacokinetic measures.
Transplantation proceedings 1993;25(2 Suppl 1):83-5.
1993: Kimball J A; Norman D J; Shield C F; Schroeder T J; Lisi P; Garovoy M; O'Connell J B; Stuart F; McDiarmid S V; Wall W
OKT3 antibody response study: comparative testing of human antimouse antibody.
Transplantation proceedings 1993;25(2 Suppl 1):74-6.
1993: Norman D J; Kimball J A; Barry J M
Cytokine-release syndrome: differences between high and low doses of OKT3.
Transplantation proceedings 1993;25(2 Suppl 1):35-8.
1993: Shihab F S; Barry J M; Norman D J
Encephalopathy following the use of OKT3 in renal allograft transplantation.
Transplantation proceedings 1993;25(2 Suppl 1):31-4.
1993: Batiuk T D; Bennett W M; Norman D J
Cytokine nephropathy during antilymphocyte therapy.
Transplantation proceedings 1993;25(2 Suppl 1):27-30.
1993: Norman D J
Rationale for OKT3 monoclonal antibody treatment in transplant patients.
Transplantation proceedings 1993;25(2 Suppl 1):1-3.
1993: Norman D J; Bennett W M; Cobanoglu A; Hershberger R; Hosenpud J D; Meyer M M; Misiti J; Ott G; Ratkovec R; Shihab F
Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
Transplantation proceedings 1993;25(1 Pt 1):802-3.
1993: Henell K R; Cheever J M; Kimball J A; Lye W C; Munar M Y; Misiti J; Vitow C; Norman D J
OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.
Transplantation proceedings 1993;25(1 Pt 1):800-1.
1993: Shihab F; Barry J M; Bennett W M; Meyer M M; Norman D J
Cytokine-related encephalopathy induced by OKT3: incidence and predisposing factors.
Transplantation proceedings 1993;25(1 Pt 1):564-5.
1993: Kimball J A; Norman D J; Shield C F; Schroeder T J; Lisi P; Garovoy M; O'Connell J B; Stuart F; McDiarmid S V; Wall W
OKT3 antibody response study (OARS): a multicenter comparative study.
Transplantation proceedings 1993;25(1 Pt 1):558-60.
1993: Batiuk T D; Barry J M; Bennett W M; Meyer M M; Tolzman D; Norman D J
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
Transplantation proceedings 1993;25(1 Pt 2):1391.
1993: Norman D J; Kahana L; Stuart F P; Thistlethwaite J R; Shield C F; Monaco A; Dehlinger J; Wu S C; Van Horn A; Haverty T P
A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Transplantation 1993;55(1):44-50.
1992: Wetzsteon P J; Head M A; Fletcher L A; Norman D J
Confidence levels assigned to serologic HLA-DR typing predict DNA HLA-DR typing discrepancies.
Transplantation proceedings 1992;24(6):2483-4.
1992: Lye W C; Head M A; Wetzsteon P J; Fletcher L A; Norman D J
Cytotoxic B-cell crossmatches: comparing three techniques.
Transplantation proceedings 1992;24(5):1685-6.
1992: Lye W C; Henell K R; Norman D J
Antiphospholipid antibodies causing positive flow crossmatches and interfering with T-cell immunophenotyping.
Transplantation proceedings 1992;24(5):1683-4.
1992: Wetzsteon P J; Head M A; Fletcher L M; Lye W C; Norman D J
Cytotoxic flow-cytometric crossmatches (flow-tox): a comparison with conventional cytotoxicity crossmatch techniques.
Human immunology 1992;35(2):93-9.
1992: Munson J L; Bennett W M; Barry J M; Norman D J
A case control study of renal transplantation in patients with type I diabetes.
Clinical transplantation 1992;6(4):306-11.
1992: Shield C F; Kahana L; Pirsch J; Vergne-Marini P; First M R; Schroeder T J; Cohen D; Norman D J; Monaco A; Martinez A
Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejection.
Transplantation 1992;54(1):164-6.
1992: Hosenpud J D; Hershberger R E; Ratkovec R R; Hovaguimian H; Ott G; Cobanoglu A; Norman D
Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(4 Pt 1):739-45.
1992: Norman D J
Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy.
Seminars in nephrology 1992;12(4):315-24.
1992: Everett J P; Hershberger R E; Norman D J; Chou S; Ratkovec R M; Cobanoglu A; Ott G Y; Hosenpud J D
Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(3 Pt 2):S133-7.
1992: Oni A A; Hershberger R E; Norman D J; Ray J; Hovaguimian H; Cobanoglu A M; Hosenpud J D
Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(2 Pt 1):367-9.
1991: Maricle R A; Hosenpud J D; Norman D J; Pantely G A; Cobanoglu A M; Starr A
The lack of predictive value of preoperative psychologic distress for postoperative medical outcome in heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1991;10(6):942-7.
1991: Payami H; Kaye J; Becker W; Norman D; Wetzsteon P
HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men.
Neurology 1991;41(10):1544-8.
1991: Norman D J; Costanzo-Nordin M R
Renal transplantation for the nephrologist: why we need transplantation medicine.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;18(3):394-7.
1991: Nathan D M; Fogel H; Norman D; Russell P S; Tolkoff-Rubin N; Delmonico F L; Auchincloss H; Camuso J; Cosimi A B
Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus.
Transplantation 1991;52(1):85-91.
1991: Hosenpud J D; Hershberger R E; Pantely G A; Norman D J; Hovaguimian H; Cobanoglu A; Starr A
Late infection in cardiac allograft recipients: profiles, incidence, and outcome.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1991;10(3):380-6.
1991: Norman D J; Barry J M; Bennett W M; Munson J L; Meyer M; Henell K; Kimball J; Hubert B
OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.
Transplantation proceedings 1991;23(1 Pt 2):1052-4.
1991: Henell K R; Bakke A; Kenny T A; Kimball J A; Barry J M; Norman D J
Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.
Transplantation proceedings 1991;23(1 Pt 2):1070-1.
1991: Norman D J; Leone M R
The role of OKT3 in clinical transplantation.
Pediatric nephrology (Berlin, Germany) 1991;5(1):130-6.
1991: Norman D J; Bennett W M; Wetzsteon P J; Hefty T; Meyer M M; Tolzman D; Seely M; Millhollen M; Barry J M
Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990.
Clinical transplants 1991;():153-7.
1990: Coleman A E; Norman D J
OKT3 encephalopathy.
Annals of neurology 1990;28(6):837-8.
1990: Leone M R; Alexander S R; Melvin T; Striegel J; Reller K; Norman D J; Barry J M
A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
The Journal of urology 1990;144(3):721-3.
1990: Hosenpud J D; Norman D J; Pantely G A
Low-dose oral prednisone in the treatment of acute cardiac allograft rejection not associated with hemodynamic compromise.
The Journal of heart transplantation 1990;9(3 Pt 2):292-6.
1990: Hosenpud J D; Pantely G A; Morton M J; Wilson R A; Norman D J; Cobanoglu A M; Starr A
Lack of progressive "restrictive" physiology after heart transplantation despite intervening episodes of allograft rejection: comparison of serial rest and exercise hemodynamics one and two years after transplantation.
The Journal of heart transplantation 1990;9(2):119-23.
1990: Hosenpud J D; Pantely G A; Norman D J; Cobanoglu A M; Hovaguimian H; Starr A
A critical analysis of morbidity and mortality as it relates to recipient age following cardiac transplantation.
Clinical transplantation 1990;4(1):51-4.
1990: Norman D J
The clinical role of OKT3.
Cardiology clinics 1990;8(1):97-105.
1989: Maricle R A; Hosenpud J D; Norman D J; Woodbury A; Pantley G A; Cobanoglu A M; Starr A
Depression in patients being evaluated for heart transplantation.
General hospital psychiatry 1989;11(6):418-24.
1989: Hosenpud J D; Morton M J; Wilson R A; Pantely G A; Norman D J; Cobanoglu M A; Starr A
Abnormal exercise hemodynamics in cardiac allograft recipients 1 year after cardiac transplantation. Relation to preload reserve.
Circulation 1989;80(3):525-32.
1989: Hosenpud J D; Pantely G A; Morton M J; Norman D J; Cobanoglu A M; Starr A
Relation between recipient: donor body size match and hemodynamics three months after heart transplantation.
The Journal of heart transplantation 1989;8(3):241-3.
1989: Hosenpud J D; Norman D J; Pantely G A; Cobanoglu A M; Starr A
OKT3-induced hypotension in heart allograft recipients treated for steroid-resistant rejection.
The Journal of heart transplantation 1989;8(2):159-65; discussion 165-6.
1989: Bennett W M; Hosenpud J; Pantley G; Cobanoglu A; Starr A; Norman D J
Renal consequences of a low dose cyclosporine triple therapy regimen in cardiac transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2479-80.
1989: Wetzsteon P J; Head M A; Fletcher L A; Barry J M; Norman D J
Successful transplantation across positive crossmatches: a result of detailed pretransplant antibody analysis.
Transplantation proceedings 1989;21(1 Pt 1):714-5.
1989: Henell K R; Chou S; Norman D J
Use of cytomegalovirus-seropositive donor kidneys in seronegative patients: results of prospective serotesting and matching in one center.
Transplantation proceedings 1989;21(1 Pt 2):2082-3.
1989: Shield C F; Hughes J D; Marlett P; Norman D J
The human antimouse reaction to OKT3: cross-reactive pattern analysis using a large group of anti-CD3 and isotypic monoclonal antibodies.
Transplantation proceedings 1989;21(1 Pt 1):981-4.
1988: Norman D J
An overview of the use of the monoclonal antibody OKT3 in renal transplantation.
Transplantation proceedings 1988;20(6):1248-52.
1988: Bohannon L L; Barry J M; Norman D J; Bennett W M
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation.
The Journal of urology 1988;140(4):810-1.
1988: Goldstein G; Norman D J; Henell K R; Smith I L
Pharmacokinetic study of orthoclone OKT3 serum levels during treatment of acute renal allograft rejection.
Transplantation 1988;46(4):587-9.
1988: Norman D J; Shield C F; Henell K R; Kimball J; Barry J M; Bennett W M; Leone M
Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
Transplantation 1988;46(4):523-9.
1988: Chou S W; Norman D J
The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
Transplantation 1988;46(1):89-93.
1988: Conner R; Hosenpud J D; Norman D J; Pantely G A; Cobanoglu A; Starr A
Heart transplantation for cardiac amyloidosis: successful one-year outcome despite recurrence of the disease.
The Journal of heart transplantation 1988;7(2):165-7.
1988: Barry J M; Shively N; Hubert B; Hefty T; Norman D J; Bennett W M
Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
Transplantation 1988;45(2):346-8.
1988: Shield C F; Norman D J
Immunologic monitoring during and after OKT3 therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):120-4.
1988: Norman D J; Shield C F; Barry J; Bennett W M; Henell K; Kimball J; Funnell B; Hubert B
Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):107-10.
1988: Norman D J; Barry J M; Bennett W M; Leone M; Henell K; Funnell B; Hubert B
The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):90-3.
1988: Norman D J; Illingworth D R; Munson J; Hosenpud J
Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.
The New England journal of medicine 1988;318(1):46-7.
1988: Norman D J
Monoclonal antibody OKT3 in cardiac and renal transplantation.
Bibliotheca cardiologica 1988;(43):27-32.
1987: Hosenpud J D; Norman D J; Cobanoglu M A; Floten H S; Conner R M; Starr A
Serial echocardiographic findings early after heart transplantation: evidence for reversible right ventricular dysfunction and myocardial edema.
The Journal of heart transplantation 1987;6(6):343-7.
1987: Leone M R; Alexander S R; Barry J M; Henell K; Funnell M B; Goldstein G; Norman D J
OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection.
The Journal of pediatrics 1987;111(1):45-50.
1987: Norman D J; Shield C F; Barry J; Henell K; Funnell M B; Lemon J
A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
Transplantation proceedings 1987;19(2 Suppl 1):21-7.
1987: Chou S; Kim D Y; Norman D J
Transmission of cytomegalovirus by pretransplant leukocyte transfusions in renal transplant candidates.
The Journal of infectious diseases 1987;155(3):565-7.
1987: Norman D J; Fletcher L; Barry J
A randomized study of buffy coat transfusions in cadaveric renal transplantation.
Transplantation proceedings 1987;19(1 Pt 3):1967-70.
1987: Norman D J; Henell K; Fletcher L; Barry J
Donor specific transfusions: a five-year experience with alternative protocols.
Transplantation proceedings 1987;19(1 Pt 3):2252-4.
1987: Norman D J; Wetzsteon P; Barry J M; Bennett W M
Cyclosporine versus azathioprine in high risk cadaver kidney transplant recipients: a prospective randomized study.
Transplantation proceedings 1987;19(1 Pt 3):1845.
1987: Shield C F; Norman D J; Marlett P; Fucello A J; Goldstein G
Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin.
Nephron 1987;46 Suppl 1():48-51.
1987: Norman D J; Shield C F; Barry J M; Henell K; Funnell M B; Lemon J
Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejection.
Nephron 1987;46 Suppl 1():41-7.
1986: Goldstein G; Fuccello A J; Norman D J; Shield C F; Colvin R B; Cosimi A B
OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3.
Transplantation 1986;42(5):507-11.
1986: Barry J M; Serra J R; Hefty T R; Norman D J; Bennett W M
Low dose cyclosporine strategy for cadaver kidney transplantation.
Transplantation proceedings 1986;18(2 Suppl 1):125-7.
1986: Norman D J; Barry J M; Fischer S
The beneficial effect of pretransplant third-party blood transfusions on allograft rejection in HLA-identical sibling kidney transplants.
Transplantation 1986;41(1):125-6.
1986: Goldstein G; Norman D J; Shield C F; Kreis H; Burdick J; Flye M W; Rivolta E; Starzl T; Monaco A
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Progress in clinical and biological research 1986;224():239-49.
1986: Bennett W M; Norman D J
Action and toxicity of cyclosporine.
Annual review of medicine 1986;37():215-24.
1985: Hatch D A; Barry J M; Norman D J
A randomized study of intravenous fluid replacement following living-donor renal transplantation.
Transplantation 1985;40(6):648-51.
1985: Leone M R; Funnell B; Jenkins R D; Alexander S R; Goldstein G; Barry J M; Norman D J
Monoclonal antibody for reversal of acute renal allograft rejection in pediatric patients.
Transplantation 1985;40(5):574-7.
1985: Barry J M; Norman D J; Bennett W M
Pediatric cadaver kidney transplants into adults.
The Journal of urology 1985;134(4):651-3.
1985: Barry J M; Hefty T; Fischer S M; Norman D J
Donor specific blood transfusions and successful spousal kidney transplantation.
The Journal of urology 1985;133(6):1024-5.
1985: Bennett W M; Serra J; Fischer S; Norman D J; Barry J M
Cyclosporine in renal transplantation with hirsutism.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1985;5(3):214.
1985: Norman D J; Barry J M; Wetzsteon P J
Successful cadaver kidney transplantation in patients highly sensitized by blood transfusions. Unimportance of the most reactive serum in the pretransplant crossmatch.
Transplantation 1985;39(3):253-5.
1984: Kreis H; Norman D; Martin P
Status of monoclonals used therapeutically in transplantation.
Transplantation proceedings 1984;16(6):1655-7.
1984: Barry J M; Norman D; Fuchs E F; Fischer S; Bennett W M
Influence of acute tubular necrosis on first cadaver kidney transplant function.
The Journal of urology 1984;132(2):234-6.
1984: Barry J M; Norman D J; Fischer S M; Bennett W M
Prolonged human kidney preservation by intracellular electrolyte flush followed by cold storage.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1984;3(4):293-6.
1983: Bohannon L L; Norman D J; Barry J; Bennett W M
Cadaveric renal transplantation in a patient with primary hyperoxaluria. A case report.
Transplantation 1983;36(1):114-5.
1983: Wickre C G; Norman D J; Bennison A; Barry J M; Bennett W M
Postrenal transplant erythrocytosis: a review of 53 patients.
Kidney international 1983;23(5):731-7.
1983: Barry J M; Larson B; Fischer S M; Norman D J; Bennett W M
Beneficial effect of pre-transplant splenectomy for leukopenia in primary cadaver kidney transplants.
The Journal of urology 1983;129(3):479-80.
1982: Bennett W M; Barry J M; Norman D J; Elliott W C
Tubular transport capacity in human kidney cortex slices after prolonged preservation in Collins 2 solution.
Urology 1982;19(6):626-7.
1982: Bennett W M; Bardana E J; Norman D J; Houghton D C
Natural history of "silent" lupus nephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1982;1(6):359-63.
1982: Barry J M; Frankus E; Norman D J; Bennett W M
Comparison of standard immunosuppression with adjuvant antilymphoblast globulin in primary cadaver kidney transplant survival.
Urology 1982;19(3):287-9.
1982: Norman D J; Barry J M; VanderWerf B A
Regional kidney sharing program for patients with broadly reactive lymphocytotoxic antibodies.
The Western journal of medicine 1982;136(2):181-3.
1981: Norman D J; Black R M; Shadur C A; Strom T B; Carpenter C B
Continuous density gradient separation of allosensitized cells from a mixed lymphocyte culture.
Transplantation proceedings 1981;13(2):1469-71.
1980: Fisher P B; Bennett W M; Norman D; Barry J M
Intravenous versus subcutaneous insulin in the postoperative juvenile-onset diabetes mellitus (JODM) patient receiving a renal cadaver transplant.
Proceedings of the Clinical Dialysis and Transplant Forum 1980;10():258-9.
1979: Carpenter C B; Terranova C M; Milford E L; Lowry R P; Vitetta E; Paradysz J M; Norman D J; Norris S
Evidence for a second class II (Ia) antigenic system in rats linked to RT1.
Transplantation proceedings 1979;11(3):1582-3.
1979: Norman D J; Carpenter C B; Paradysz J M
Renal transplantation of RT1-B-matched, RT1-A-mismatched rats.
Transplantation proceedings 1979;11(1):486-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Douglas Norman

Research Profile (preview)

Procedures

Physiology

Chemicals & Drugs

Living Beings

Concepts & Ideas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Douglas Norman (preview)

All Publications